Huateng Pharma, a leading and professional pharmaceutical APIs & intermediates manufacturer, offers oseltamivir Intermediates Ethyl 4-acetamido-3-hydroxybenzoate, CAS NO.1346604-18-9 for your requirements of R&D, evaluation, pilots and commercial along with a supportive technical package required for evaluation.
*The following content is generated by AI and is for reference only.
Ethyl 4-acetamido-3-hydroxybenzoate is a specialized organic compound belonging to the class of substituted benzoates, widely recognized in pharmaceutical and chemical synthesis sectors. With the molecular formula C11H13NO4 and a molecular weight of approximately 223.22 g/mol, this substance serves as a crucial intermediate in the production of various bioactive molecules. Its Chemical Abstracts Service (CAS) registry number is 6198-75-0, providing a unique identifier for regulatory compliance and safety data sheet management globally.
The structural configuration features an ethyl ester group, an acetamido moiety, and a hydroxyl group positioned on the benzene ring at specific intervals. This unique arrangement imparts distinct physicochemical properties, including moderate solubility in polar organic solvents like ethanol and dimethyl sulfoxide, while remaining relatively insoluble in water. These characteristics make it highly valuable for researchers developing novel drug candidates, particularly those targeting anti-inflammatory or analgesic pathways. In industrial applications, Ethyl 4-acetamido-3-hydroxybenzoate acts as a key building block for synthesizing complex heterocyclic compounds and advanced polymer additives.
Its primary utility lies in medicinal chemistry, where it facilitates the creation of derivatives with enhanced biological activity. The presence of the hydroxyl and acetamido groups allows for further functionalization through standard organic reactions such as acylation, alkylation, or reduction. Consequently, it is frequently employed in laboratory settings to explore structure-activity relationships (SAR) during early-stage drug discovery processes. Furthermore, due to its stability under standard storage conditions when kept in cool, dry environments away from direct sunlight, it is suitable for long-term inventory management by chemical suppliers and research institutions.
Safety protocols dictate that handling should occur in well-ventilated areas with appropriate personal protective equipment, as with most synthetic organic intermediates. While not typically classified as a high-risk hazardous material, proper disposal methods must be followed to prevent environmental contamination. As the demand for sophisticated therapeutic agents grows, Ethyl 4-acetamido-3-hydroxybenzoate remains an essential component in the global chemical supply chain, bridging the gap between basic raw materials and finished pharmaceutical products. Its versatility ensures continued relevance in both academic research and commercial manufacturing operations focused on health and wellness solutions.